检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]广东省惠州市第二妇幼保健院麻醉科,广东惠州516001
出 处:《临床医学工程》2014年第6期717-718,共2页Clinical Medicine & Engineering
摘 要:目的探讨小剂量罗呱卡因复合舒芬太尼蛛网膜下腔麻醉用于剖宫产的临床效果。方法通过对2012年2月至2013年10月在我院进行剖宫产的90例产妇,随机分为对照组和实验组,每组均为45例产妇。对照组产妇仅给予小剂量罗呱卡因进行麻醉,实验组产妇给予小剂量罗呱卡因复合舒芬太尼进行麻醉。观察比较两组产妇的麻醉效果,产妇麻醉效果的满意度及不良反应发生情况。结果实验组产妇麻醉剂起效时间较对照组产妇明显降低,具有显著差异(P<0.05);实验组产妇的总满意度较对照组患者明显提高,具有显著性差异(P<0.05);实验组患者的不良反应发生率较对照组患者明显降低,具有显著性差异(P<0.05)。结论针对剖宫产产妇采用小剂量罗呱卡因复合舒芬太尼,具有显著的麻醉效果,提高患者的满意度,降低不良反应的发生率。小剂量罗呱卡因复合舒芬太尼对蛛网膜下腔麻醉剖宫产具有十分重要的临床意义,值得推广应用。Objective To investigate the clinical efficacy of small doses of ropivacaine combined with sufentanil in subarachoid anesthesia for cesarean. Methods 90 cases of maternal cesarean from February 2012 to October 2013 in our hospital were randomly divided into control group and experimental group, with 45 cases in each. The control group only received a small dose of ropivacaine as anesthesthetic, while the experimental group were given small doses of ropivacaine combined with sufentanil. The primary outcome was a composite of anesthetic efficacy, patients&#39; satisfaction and adverse reactions. Results The onset time of the anesthetic in the experimental group was significant lower than that in the control groups (P &lt;0.05);the degree of satisfaction in the experimental group was significantly higher than that in the control group (P &lt;0.05);the incidencd of adverse reactions in the experimental group were significantly lower than that in the control group (P&lt;0.05). Conclusions Small doses of ropivacaine combined with sufentanil was a remarkably effective anesthetic for cesarean, which improves patient satisfaction, and reduces the incidence of adverse reactions. It has important clinical significance as subarachoid anesthesia for cesarean, which is worthy to promote widely.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.119.107.255